
|Videos|September 12, 2021
Dr. Elliot on ROBUST III trial of Optilume drug-coated balloon for anterior urethral strictures
Author(s)Urology Times staff
Interim results from the ROBUST III trial were presented at the 2021 AUA Annual Meeting.
Advertisement
In this video, Sean P. Elliott, MD, MS, FACS, discusses the abstract, “Interim results for the ROBUST III trial evaluating the Optilume drug-coated balloon for anterior urethral strictures,” which was presented during the 2021 American Urological Association annual meeting. Elliott is a professor, vice chair of urology, and director of reconstructive urology at the University of Minnesota, Minneapolis.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Treatment Selection in Advanced Prostate Cancer
4
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
5






